Zyphar’s Biopharmaceuticals delivers integrated, end-to-end solutions for Oncology APIs and Bulk Drugs, supported by advanced infrastructure, strong analytical capabilities, and proven regulatory expertise.

ONCOLOGY API'S

Product Pharmacopoeia Product Status
ACALABRUTINIBIHDMF + TECH PACK
ABIRATERONE ACETATEIP/USPDMF + TECH PACK
BORTEZOMIBIPTECH PACK
CAPECITABINEIP/USPDMF + TECH PACK
CRIZOTINIBIHDMF + TECH PACK
DASATINIBIH/IPDMF + TECH PACK
DOCETAXEL ANHYDROUSIP/BP/USPDMF + TECH PACK
DOCETAXEL TRIHYDRATEIP/BP/USPDMF + TECH PACK
ELTROMBOPAG OLAMINEIHDMF + TECH PACK
FOSAPREPITANT (As Dimeglumine)IHTECH PACK
GEMCITABINE HYDROCHLORIDEIP/BP/EP/USPDMF + TECH PACK
IBRUTINIBIHDMF + TECH PACK
IFOSFAMIDEIP/EP/USPDMF + TECH PACK
IMATINIB MESYLATEIP/BP/EPDMF + TECH PACK
LAPATINIBIPDMF + TECH PACK
LENALIDOMIDEIHDMF + TECH PACK
NILOTINIB HCL MONOHYDRATEBP/EPDMF + TECH PACK
PACLITAXELIP/BP/USPDMF + TECH PACK
PALBOCICLIBIHDMF + TECH PACK
PAZOPANIB HCLIHDMF + TECH PACK
PEMETREXED DISODIUMUSPTECH PACK
PLERIXAFORIHTECH PACK
TEMOZOLOMIDEEP/IP/USPDMF + TECH PACK
THALIDOMIDEIP/USPDMF + TECH PACK
VENETOCLAXIHTECH PACK
VINBLASTINEIP/BP/EP/USPTECH PACK
VINCRISTINEIP/BP/EP/USPTECH PACK
VINORELBINEIP/BP/EP/USPTECH PACK

UNDER COMMERCIALIZATION

ABEMACICLIB CABOZANTINIB HCL CABOZANTINIB S-MALEATE
REGORAFENIB RIBOCICLIB RUCAPARIB
RUXOLITINIB
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. Also the onus of patent applicability shall remain with Importer.